Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GoodRx Holdings Inc GDRX

GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers... see more

Recent & Breaking News (NDAQ:GDRX)

Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm

PR Newswire 9 days ago

GoodRx Reports Third Quarter 2024 Results

Business Wire November 7, 2024

GoodRx to Participate in Upcoming Investor Conferences

Business Wire November 4, 2024

GoodRx Unveils New E-commerce Platform, Launches with Opill®

Business Wire October 31, 2024

GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults

Business Wire October 29, 2024

GoodRx Announces New Affordability Programs for Menopause Hormone Therapies

Business Wire October 23, 2024

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers

Business Wire October 16, 2024

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call

Business Wire October 10, 2024

GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)

Business Wire September 26, 2024

Notice to Long-Term Investors of GoodRx Holdings, Inc. (GDRX): Grabar Law Office Is Investigating Claims on Your Behalf

Newsfile August 30, 2024

GoodRx to Participate in Upcoming Investor Conferences

Business Wire August 21, 2024

GoodRx Reports Second Quarter 2024 Results

Business Wire August 8, 2024

Alert to Long-term Investors of GoodRx Holdings, Inc. (GDRX): Grabar Law Office Is Investigating Claims on Your Behalf

Newsfile July 29, 2024

Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira®

PR Newswire July 18, 2024

GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call

Business Wire July 11, 2024

Ian T. Clark Joins GoodRx Board of Directors

Business Wire July 10, 2024

GoodRx Launches New "Prescription Cost Tracker" to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.

Business Wire June 26, 2024

Lifshitz Law PLLC Announces Investigations of Nextdoor Holdings, Inc. (NYSE: KIND), GoodRx Holdings, Inc. (NASDAQ: GDRX), Mercury Systems, Inc. (NASDAQ: MRCY), and Ventyx Biosciences, Inc. (NASDAQ: VTYX)

Accesswire June 24, 2024

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx

Newsfile June 23, 2024

Lifshitz Law PLLC Announces Investigations of GoodRx Holdings, Inc. (NASDAQ:GDRX), Doximity, Inc. (NYSE:DOCS), agilon health, inc. (NYSE:AGL), and Sharecare, Inc. (NASDAQ:SHCR)

Accesswire June 22, 2024